Andrea Pfeifer
Founder bij AC IMMUNE SA
Vermogen: 7 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Andrea Pfeifer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
41
| Public Company | Pharmaceuticals: Major | 41 |
33
| Public Company | Chemicals: Specialty | 33 |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.
7
| Private Company | Pharmaceuticals: Major | 7 |
University of Lausanne
7
| College/University | Other Consumer Services | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andrea Pfeifer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| BERTELSMANN SE & CO. KGAA | Movies/Entertainment | Director of Finance/CFO Chief Executive Officer | |
Bertelsmann, Inc.
 Bertelsmann, Inc. BroadcastingConsumer Services Bertelsmann, Inc. provides television broadcasting and book and music publishing services. Its core divisions include (RTL Group), book publishing (Penguin Random House), magazine publishing (Gruner + Jahr), services (Arvato), and printing (Be Printers). The company was founded on March 27, 1981 and is headquartered in New York, NY. | Broadcasting | Director/Board Member Chairman | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| PROBI AB | Biotechnology | Chairman Director/Board Member | |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Founder Founder | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Founder Founder Founder Founder | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| RTL GROUP S.A. | Broadcasting | Director/Board Member Chief Executive Officer | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| COVESTRO AG | Chemicals: Specialty | Corporate Officer/Principal Corporate Officer/Principal | |
| University of St. Gallen | College/University | Masters Business Admin Director/Board Member Corporate Officer/Principal | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Gottingen | College/University | Graduate Degree Undergraduate Degree | |
| University of Hannover | College/University | Graduate Degree Doctorate Degree | |
| University of Basel | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Zurich | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Ghent University | College/University | Graduate Degree Graduate Degree | |
| University of Milan | College/University | Corporate Officer/Principal Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Director/Board Member Doctorate Degree | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder Chief Executive Officer | |
| NOVIMMUNE SA | Medical/Nursing Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
Industriegewerkschaft Bergbau Chemie Energie
 Industriegewerkschaft Bergbau Chemie Energie Miscellaneous Commercial ServicesCommercial Services Industriegewerkschaft Bergbau Chemie Energie operates as a trade union. The private company is based in Hannover, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Julius-Maximilians-Universität Würzburg | College/University | Undergraduate Degree Doctorate Degree | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer Chief Executive Officer | ||
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
Penguin Random House Ltd.
 Penguin Random House Ltd. Publishing: Books/MagazinesConsumer Services Penguin Random House Ltd. publishes and distributes books. It offers fiction, non fiction, and children's books. The company was founded on September 5, 1962 and is headquartered in London, the United Kingdom. | Publishing: Books/Magazines | Director/Board Member Director/Board Member | |
| SWEDENCARE AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member Founder | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member | |
Covestro Deutschland AG
 Covestro Deutschland AG Chemicals: SpecialtyProcess Industries Covestro Deutschland AG engages in the production and distribution of polymers. It also sells paints and adhesive raw materials. The company was founded on April 8, 2002 and is headquartered in Leverkusen, Germany. | Chemicals: Specialty | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Chairman |
Statistieken
Internationaal
| Duitsland | 28 |
| Verenigde Staten | 10 |
| Zwitserland | 7 |
| Zweden | 3 |
| Italië | 3 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 17 |
| Process Industries | 3 |
| Health Services | 3 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 336 |
| Corporate Officer/Principal | 171 |
| Chairman | 139 |
| Independent Dir/Board Member | 73 |
| Chief Executive Officer | 67 |
Sterkste connecties
| Insiders | |
|---|---|
| Sanna Suvanto-Harsaae | 71 |
| Christof Hettich | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| Thomas Hermann Rabe | 33 |
| Alan Colowick | 27 |
| Douglas Williams | 25 |
| Monika Bütler | 25 |
| Andreas G. Schmid | 25 |
| Michael König | 23 |
| Thomas D. Szucs | 23 |
| Jan Zijderveld | 21 |
| Winfried Steeger | 20 |
| Mathias Hothum | 19 |
| Peter Vanacker | 17 |
| Detlev Riesner | 16 |
- Beurs
- Insiders
- Andrea Pfeifer
- Bedrijfsconnecties
